Status:
RECRUITING
Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
British Heart Foundation
Conditions:
Telangiectasia, Hereditary Hemorrhagic
Eligibility:
All Genders
Brief Summary
This study will examine genes involved in the vascular dysplasia Hereditary haemorrhagic telangiectasia i(HHT)
Detailed Description
Hereditary haemorrhagic telangiectasia (HHT) is a condition inherited as an autosomal dominant trait. Sequencing DNA from affected and unaffected family members allows us to identify disease-causal ge...
Eligibility Criteria
Inclusion
- Member of family affected by HHT
Exclusion
- Unable or unwilling to provide informed consent for DNA sample
Key Trial Info
Start Date :
December 1 1998
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00230620
Start Date
December 1 1998
End Date
April 1 2030
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Hammersmith Campus
London, United Kingdom, W12 0NN